Innventure Inc. (NASDAQ:INV) Reports Q3 2025 Revenue Miss and Widening Losses

Innventure Reports Q3 2025 Results: Revenue Misses, Losses Widen

Earnings Snapshot

Innventure, Inc. (NASDAQ:INV) has released its financial results for the third quarter of 2025. The industrial growth conglomerate reported figures that fell short of analyst expectations on the top line while posting a larger-than-anticipated loss.

The company's reported performance against Wall Street estimates is summarized below:

• Revenue: $0.53 million versus an estimate of $1.99 million.
• Earnings Per Share (EPS): -$0.51 versus an estimate of -$0.09.

Market Reaction

The market's immediate response to the earnings release was decisively negative. In after-hours trading following the announcement, shares of Innventure declined by approximately 9.8%. This sell-off suggests investor disappointment with both the significant revenue miss and the deeper-than-expected quarterly loss.

Operational Highlights and Strategic Progress

Despite the financial shortfall, the company's earnings press release highlighted several areas of strategic progress across its portfolio of operating companies. Management emphasized execution on key commercial and technical milestones, framing the quarter as part of a "pivotal phase of growth."

Key developments from the quarter include:

• Accelsius: The data center cooling unit secured a strategic investment from Johnson Controls and introduced its NeuCool® MR250 system. The company showcased its technology at NVIDIA GTC, demonstrating thermal performance of up to 4,500W per GPU socket. Notably, Accelsius reported that its sales pipeline now exceeds $1 billion.
• AeroFlexx: The packaging technology company delivered its fifth consecutive quarter of revenue generation. The company is also expanding its global footprint, citing a growing customer pipeline in both the U.S. and Europe and a new partnership with ĕleeo brands.
• Refinity: The waste-to-value technology company remains on track to demonstrate pilot scale and finalize the initial site selection for its first plant by the end of the year.

CEO Bill Haskell stated that the company is "poised to deliver meaningful revenue growth in the quarters and years ahead," underscoring a focus on long-term value creation through its unique model of commercializing breakthrough technologies.

Financial Health and Balance Sheet

A review of the condensed balance sheet reveals a mixed financial position. While total assets decreased significantly from $905.3 million at the end of 2024 to $556.5 million as of September 30, 2025, this was largely attributable to a goodwill impairment charge recognized earlier in the year. The company reported cash and cash equivalents of $9.1 million, down from $11.1 million at year-end 2024. Total liabilities saw a modest increase to $149.9 million, up from $139.0 million at the end of the prior year.

Looking Ahead

The press release did not provide a specific quantitative financial outlook for the upcoming quarter or the full year. This leaves investors to rely on current analyst projections, which estimate Q4 2025 revenue of $4.37 million with an EPS of -$0.09. For the full year 2025, analysts are estimating sales of $7.0 million. The absence of company-provided guidance means the market must weigh the promising operational updates against the hard financial data from Q3.

For a detailed breakdown of historical earnings, future estimates, and analyst projections, you can review the data here.

Disclaimer: This article is for informational purposes only and is not intended as investment advice. All investment decisions carry risk, and individuals should conduct their own research or consult with a qualified financial advisor before making any investment decisions.